It has been shown that the increase expression of TNFα can stimulate hepcidin generation, and the application of TNFα inhibitors can reduce hepcidin production and improve anemia (Atkinson et al. 2018; Song et al. 2013). The gene discussed is HAMP; the disease is anemia (phenotype).